Skip to main content
Camille Abboud, MD, Oncology, St. Louis, MO

Camille N Abboud MD

Oncology•St. Louis, MO

Hematologic Oncology

Professor of Medicine Section BMT and Leukemia

Join to view full profile

  • 4500 Forest Park AveDiv IM Bone Marrow Transplant 5TH 6TH 8TH FLSt. Louis, MO 63108

  • Phone+1 314-454-8304

  • Fax+1 314-454-5902

Dr. Abboud is on Doximity

As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.
See Dr. Abboud's full profileAlready have an account?

Summary

  • Dr. Camille Abboud is an oncologist in Saint Louis, MO and is affiliated with multiple hospitals in the area, including Barnes-Jewish Hospital and Siteman Cancer Center. He received his medical degree from American University of Beirut Faculty of Medicine and has been in practice 43 years. He also speaks multiple languages, including French and Arabic. He specializes in hematologic oncology and is experienced in hematologic oncology, acute myeloid leukemia, hairy cell leukemia, lymphoma, and cellular therapy including marrow and peripheral blood stem cell transplants and CAR-T treatment of lymphoma, myeloma and Acute Lymphoblastic Leukemia.

Education & Training

  • Rutgers Health/New Jersey Medical School
    Rutgers Health/New Jersey Medical SchoolResidency, Internal Medicine, 1974 - 1976
  • American University of Beirut Faculty of Medicine
    American University of Beirut Faculty of MedicineClass of 1974

Certifications & Licensure

  • IL State Medical License
    IL State Medical License 2020 - 2029
  • MO State Medical License
    MO State Medical License 2006 - 2027
  • NY State Medical License
    NY State Medical License 1975 - 2022
  • Internal Medicine
    American Board of Internal Medicine Internal Medicine
  • Hematology
    American Board of Internal Medicine Hematology

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 1 Certification Follow My Health, Jardogs, 2012, 2014, 2016-2017
  • CMS Meaningful Use Stage 2 Certification Allscripts TouchWorks EHR (Complete), Allscripts, 2012, 2014, 2016-2017
  • CMS Meaningful Use Stage 1 Certification Allscripts Enterprise EHR, Allscripts, 2012, 2014, 2016-2017

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Single Institution Experience with G-CSF Mobilized T-cell Replete Haploidentical Hematopoietic Cell Transplantation  
    M A Schroeder, R Romee, J F DiPersio, T A Fehniger, F Gao, G L Uy, C N Abboud, P Westervelt, R Vij, Nature

Abstracts/Posters

  • Efficacy and Safety of Bosutinib By Charlson Comorbidity Index in Previously Treated Patients with Chronic Myeloid Leukemia: Results from the Phase 4 BYOND Study
    Camille Abboud, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
  • SEL120 _ a First-in-Class CDK8/19 Inhibitor As a Novel Option for the Treatment of Acute Myeloid Leukemia and High-Risk Myelodysplastic Syndrome - Data from Preclinica...
    Camille Abboud, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
  • Maintenance of Health-Related Quality of Life in the Phase 4 BYOND Study of Bosutinib for Pretreated Chronic Phase Chronic Myeloid Leukemia
    Camille Abboud, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019

Lectures

  • Evaluation of Romyelocel-L Myeloid Progenitor Cells to Decrease Infections in De Novo AML Patients Receiving High-Dose Ara-C-Based Induction Therapy 
    2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
  • A randomized open label exploratory controlled trial of CLT-008 myeloid progenitor cells (MPC) to decrease infections during induction for AML. 
    2018 ASCO Annual Meeting - Chicago, Illinois - 06/4/2018

Press Mentions

  • Siteman Cancer Center to Open North St. Louis County Location July 1
    Siteman Cancer Center to Open North St. Louis County Location July 1June 30th, 2017
  • Ruxolitinib for the Prophylaxis of Graft-Versus-Host Disease and Cytokine Release Syndrome After T-cell Replete Haploidentical Peripheral Blood Hematopoietic Cell Transplantation
    Ruxolitinib for the Prophylaxis of Graft-Versus-Host Disease and Cytokine Release Syndrome After T-cell Replete Haploidentical Peripheral Blood Hematopoietic Cell TransplantationAugust 25th, 2023

Professional Memberships

Other Languages

  • French, Arabic

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence:

Dr. Camille Abboud, Dr. Camille Abboud, MD, Dr. C Abboud, Dr. Camille N Abboud